Fluvoxamine for coronavirus infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Jan 2021: Trial registered, NCT04711863
  2. 16 Jan 2021: Trial started, NCT04711863

The trials

NCT04711863: Fluvoxamine for Adults With Mild to Moderate COVID-19

State
Suspended
Phase
Phase 2
People
400 planned
Started
16 Jan 2021
Primary completion
31 May 2021
Arms
Fluvoxamine
Results
None posted
  1. 15 Jan 2021: Trial registered
  2. 16 Jan 2021: Trial started
  3. 19 Apr 2021: Trial suspended

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.